Origin and characteristics of glycogen cells in the developing murine placenta.
The junctional zone (Jz) of the mouse placenta consists of two main trophoblast populations, spongiotrophoblasts and glycogen cells (GCs), but the development and function of both cell types are unknown. We conducted a quantitative analysis of GC size, number, and invasion of cells into the decidua across gestation. Furthermore, we identified markers of GC function to investigate their possible roles in the placenta. While the spongiotrophoblast cell volume doubles, and cell number increases steadily from E12.5 to E16.5, there is a remarkable 80-fold increase in GC numbers. This finding is followed by a notable decrease by E18.5. Surprisingly, the accumulation of GCs in the decidua did not fully account for the decrease in GC number in the Jz, suggesting loss of GCs from the placenta. Glucagons were detected on GCs, suggesting a steady glucose release throughout gestation. Connexin31 staining was shown to be specific for GCs. GC migration and invasion may be facilitated by temporally regulated expression of matrix metalloproteinase 9 and the imprinted gene product, Decorin. Expression of the clearance receptor for type II insulin-like growth factor (IGF-II), IGF2R, in a short developmental window before E16.5 may be associated with regulating the growth effects of IGF-II from glycogen cells and/or labyrinthine trophoblast on the expansion of the Jz. Thus stereology and immunohistochemistry have provided useful insights into Jz development and function of the glycogen cells.
Coan
P M
PM
Department of Physiology, Development, and Neuroscience, University of Cambridge, Downing Street, Cambridge, United Kingdom. pmc40@cam.ac.uk
Conroy
N
N
Burton
G J
GJ
Ferguson-Smith
A C
AC
D000818:Animals; D002452:Cell Count; D002465:Cell Movement; D048429:Cell Size; D017630:Connexins / Q000378:metabolism; D050761:Cyclin-Dependent Kinase Inhibitor p57 / Q000378:metabolism; D058575:Decorin; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005260:Female; D005865:Gestational Age; D005934:Glucagon / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism*; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D010920:Placenta / Q000166:cytology* / Q000378:metabolism*; D010929:Placentation; D011247:Pregnancy; D011509:Proteoglycans / Q000378:metabolism; D017527:Receptor, IGF Type 2 / Q000378:metabolism
C493965:Cdkn1c protein, mouse; D017630:Connexins; D050761:Cyclin-Dependent Kinase Inhibitor p57; C546878:DCN protein, human; C546879:Dcn protein, mouse; D058575:Decorin; D016326:Extracellular Matrix Proteins; D019394:Ki-67 Antigen; C498355:Mki67 protein, mouse; D011509:Proteoglycans; D017527:Receptor, IGF Type 2; C068044:GJB3 protein, human; D006003:Glycogen; D005934:Glucagon; D020780:Matrix Metalloproteinase 9; C501830:Mmp9 protein, mouse